HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Finck, S. J. Articles by Orszulak, T. A. Search for Related Content PubMed PubMed Citation Articles by Finck, S. J. Articles by Orszulak, T. A.

The Annals of Thoracic Surgery, Vol 55, 1192-1196, Copyright © 1993 by The Society of Thoracic Surgeons

ARTICLES

Coronary artery bypass grafting in patients with chronic lymphocytic leukemia

SJ Finck, KJ Cockerill, JE Jeter and TA Orszulak
Section of Cardiovascular and Thoracic Surgery, Mayo Clinic Jacksonville, Florida 32224.

Chronic lymphocytic leukemia is a disease of the elderly. It tends to have a variable clinical course. Because of the patients' immunologically dysfunctional state, there has been reluctance to perform open cardiac procedures because of concern about early postoperative sepsis leading to death. To assess the risk of coronary artery bypass grafting in elderly patients, the records of 26 patients (mean age, 69.6 +/- 4.9 years) with chronic lymphocytic leukemia who underwent coronary artery bypass grafting between January 1975 and July 1990 were retrospectively reviewed. Nineteen underwent isolated coronary artery bypass grafting, and 7 had combined procedures. The operative mortality rate was 7.7%. Postoperative infections developed in 6 patients (23.1%): pneumonia in 3 and sternal osteomyelitis, acute parotiditis, and bacteremia in 1 each. One of these 6 patients died of acute Serratia pneumonitis. Twenty-four patients (92.3%) were discharged from the hospital an average of 10.6 +/- 7.7 days postoperatively. Patients with chronic lymphocytic leukemia can undergo coronary artery bypass grafting with acceptable mortality but with increased risk of postoperative infection.

This article has been cited by other articles:

				A. M. Fecher, T. J. Birdas, D. Haybron, P. K. Papasavas, D. Evers, and P. F. Caushaj Cardiac operations in patients with hematologic malignancies Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 537 - 540. [Abstract] [Full Text] [PDF]

				E. V. Potapov, H. R. Zurbrugg, C. Herzke, S. Srock, H. Riess, R. Sodian, S. Hubler, and R. Hetzer Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Ann. Thorac. Surg., August 1, 2002; 74(2): 384 - 389. [Abstract] [Full Text] [PDF]

				P. Ghosh, I. Carroll, A. Kanhere, B. Ng, R. Larbalestier, and M. Edwards CARDIAC OPERATIONS IN PATIENTS WITH LOW-GRADE SMALL LYMPHOCYTIC MALIGNANCIES J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1033 - 1037. [Abstract] [Full Text] [PDF]